Experts issue call to rethink screening for breast cancer and prostate cancer
October 20, 2009
Twenty years of screening for breast and prostate cancer – the most diagnosed cancers for women and men respectively – have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and The University of Texas Health Science Center at San Antonio in an opinion piece published in the Journal of the American Medical Association.